Racial Alchemy
By Osagie K. Obasogie,
Bioethics Forum
| 05. 18. 2007
Bioethics and the Skin Tone Gene
Since the 2005 discovery that the SLC24A5 gene variant plays a sizable role in human skin pigmentation, scientists have become increasingly intrigued by the possibility of genetically manipulating skin color. Curiously, however, this research is going on with little mention of the dreaded “R” word: race.
A recent New Scientist article, for example, expends almost 3,000 words on the ins and outs of skin color’s genetic basis and apparent malleability without once mentioning race. The author eagerly notes, however, that “our skin color might one day become almost as easy to change as hair color is today, freeing us from the constraints of our genes [and] mak[ing] life far harder for those who still insist on judging people on the basis of a handful of gene variants.” Nina Jablonski’s 2006 book Skin: A Natural History devotes nearly 300 pages to understanding skin’s social, cultural, and biological significance without seriously engaging race’s long and tortured history; only two references to race appear in its index.
It is not uncommon for scientists to underestimate race’s relevance to their work. Stanford geneticist Gregory...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...